Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow NIKA PHARMACEUTICALS, INC

Get SEC filing alerts via email and in your feed for NIKA PHARMACEUTICALS, INC

NKPH NIKA

NIKA PHARMACEUTICALS, INC

About NIKA PHARMACEUTICALS, INC

Nika Pharmaceuticals Inc. develops and commercializes pharmaceutical and dietary supplement products, focusing on innovative treatments and health solutions. The company holds exclusive rights, engages in strategic mergers, and operates in global markets including Europe, Asia, and Africa. It invests in manufacturing facilities, technology acquisitions, and product development, aiming to provide healthcare solutions through partnerships, licensing, and proprietary technologies within the biotech and pharma sectors.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from NIKA PHARMACEUTICALS, INC

1
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Increased Net Loss and No Revenue in Q1 2026

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Decreased Net Loss and Strategic Developments for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Q3 2025 Financial Results with Improved Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Q2 2025 Financial Results with $18,381 Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Q1 2025 Financial Results with Reduced Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Increased Net Loss and Strategic Merger with Nika BioTechnology

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports Significant Financial Decline, Net Loss, and Increased Share Issuance in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

8
1
NIKA PHARMACEUTICALS, INC Nika Pharmaceuticals Reports First Revenue, Operating Losses, and Declining Cash Position in Q2 2024

Via official filing (AI summary) | over 1 year ago | 0 comments